GROTEKS, LLC ,   Russia

α- and β-adrenomimetic

Solution for injection 1 mg / ml.

Expectorant, mucolytic agent

Solution for ingestion and inhalation 7.5 mg / ml.

Hemostatic agent - fibrinolysis inhibitor

Solution for infusions 50 mg / ml.

Analgesic non-narcotic remedy

Solution for intravenous and intramuscular injection 500 mg / ml.

Analgesic non-narcotic remedy

Solution for intravenous and intramuscular injection 500 mg / ml.

Reparation of tissue stimulant

Solution for intramuscular injection 100 mg / ml.

Vitamin

Solution for intravenous and intramuscular injection 50 mg / ml.

Rehydrating agent

Solution for infusion.

Antitussive medication - alpha-adrenomimetic

Nasal drops 0,125 %.

Anti-glaucoma - beta-blocker

Eye drops, 0,5%.

Local anesthetic

Solution for injection, 5 mg / ml.

Solvent
Solvent for the preparation of dosage forms for injection.
Nutrition carbohydrate remedy

Solution for intravenous administration, 400 mg / ml.

Nutrition carbohydrate remedy

Solution for infusions, 5%, 10% and 20%.

Non-steroidal anti-inflammatory drug (NSAID).
Solution for intramuscular injection 25 mg / ml.
NSAIDs

Eye drops, 0,1%.

Rehydrating agent.

Solution for infusion.

For 100, 200, 250, 400, 500 or 1000 ml in polypropylene bottles, sealed with welded polypropylene caps.

One bottle together with instructions for use in a pack of cardboard.

For hospitals

From 1 to 40 vials of 100, 200, 250, 400, 500 or 1000 ml together with instructions for use in an amount equal to the number of vials in a corrugated box of cardboard.

Dorzolamide hydrochloride is a (local) inhibitor of carbonic anhydrase; Timolol maleate - (local) beta-adrenergic blocker

Eye drops 20 mg / ml + 5 mg / ml.

The antiglaucoma agent is a carbonic anhydrase inhibitor

Eye drops 20 mg / ml.

Potassium preparation

Concentrate for the preparation of a solution for infusions 40 mg / ml.

Calcium-phosphorus exchange regulator

Solution for intravenous and intramuscular injection 100 mg / ml.

Non-steroidal anti-inflammatory drug (NSAID)

Solution for intravenous and intramuscular injection 50 mg / ml.

Non-steroidal anti-inflammatory drug

Solution for intravenous and intramuscular injection 30 mg / ml.

Antimicrobial agent - fluoroquinolone

Eye drops 0.5%.

Local anesthetic

Solution for injection 20 mg / ml.

Vasodilator
Solution for intravenous administration 250 mg / ml.
Diuretics
Solution for infusions 150 mg / ml.
Non-steroidal anti-inflammatory drug (NSAID)

Solution for intramuscular injection 10 mg / ml.

Metabolic means

Solution for injection 100 mg / ml.

Antitussive medication - alpha-adrenomimetic

Nasal drops, 0.05% and 0.1%.

vitamin

Solution for injection, 10 mg / ml.

local anesthetic

Solution for injection, 0.25% and 0.5%.

Antitussive medication - alpha-adrenomimetic
Spray nasal dosed, 11.25 mcg / dose and 22.5 mcg / dose.
Antiemetic means - serotonin receptor antagonist

Solution for intravenous and intramuscular injection 2 mg / ml.

Antimicrobial agent - fluoroquinolone

Eye and ear drops 0,3%.

Spasmolytic agent.

Solution for injection 20 mg / ml.

vasodilator
Concentrate for solution for infusion, 20 mg / ml.
antiseptic

Solution for local and external use, 3%.

Nootropic agent.

Solution for intravenous and intramuscular injection 200 mg / ml.

plasma-substituting agent

Solution for infusion, 100 mg / ml.

Metabolic means.

Solution for intravenous administration of 20 mg / ml.

Electrolyte balance is a remedy.

Solution for infusion.

For 100, 200, 250, 400, 500 or 1000 ml in polypropylene bottles, sealed with welded polypropylene caps. One bottle together with instructions for use in a pack of cardboard.

For hospitals

From 1 to 40 vials of 100, 200, 250, 400, 500 or 1000 ml together with instructions for use in an amount equal to the number of vials in a corrugated box of cardboard.
Bronchodilator - beta2-adrenomimetic selective

Solution for inhalation 1 mg / ml and 2 mg / ml.

Antiallergic agent combined (H1-histamine receptor blocker + alpha-adrenomimetic)

Eye drops 0.1% + 0.033%.

Antitussive medication - alpha-adrenomimetic

Eye drops, 0.05%.

Antitussive medication - alpha-adrenomimetic

Spray nasal dosed, 35 mcg / dose and 140 mcg / dose.

Alpha-adrenomimetic

Solution for injection 10 mg / ml.

Antimicrobial agent - sulfonamide.
Eye drops 20%.
Metabolic means.

Eye drops 4%.

By 0.4 or 1 ml in drop-droppers from low-density polyethylene or polypropylene. For 5 or 10 tubes of intravenous drips in a bag of laminated paper or without it.

For 2 or 4 bags with 5 tubes or 1 or 2 bags with 10 droppers, or 10 or 20 drop-drip along with instructions for use in a pack of cardboard.

Vitamin

Solution for intramuscular injection 50 mg / ml.

Antiglaucoma means β-blocker.
Eye drops 0.5%.
5 ml per bottle with a dropper of low-density polyethylene and a lid with a control of the first opening or a flask-dropper made of high-density polyethylene, complete with a cap screwed and stopper-dropper.
For 1 or 3 bottles together with instructions for use in a pack of cardboard.
Antiglaucoma means - prostaglandin F2α analogue synthetic

Eye drops 0.005%.

M-holinoblokator

Eye drops 0.5% and 1.0%.

Ophthalmic diseases diagnostic tool (m-cholinoblocker + alpha-adrenomimetic)

Eye drops.

Alpha-adrenomimetic

Eye drops 2.5%.

Diuretics

Solution for intravenous and intramuscular injection 10 mg / ml.

Antiallergic agent - H1-histamine receptor blocker

A solution for intravenous and intramuscular administration of 20 mg / ml.

Rehydrating agent

Solution for infusion.

For 100, 200, 250, 400, 500 or 1000 ml in polypropylene bottles, sealed with welded polypropylene caps.

One bottle together with instructions for use in a pack of cardboard.

For hospitals

From 1 to 40 vials of 100, 200, 250, 400, 500 or 1000 ml together with instructions for use in an amount equal to the number of vials in a corrugated box of cardboard.

M-holinoblokator

Eye drops 1%.

Nootropic remedy

Solution for oral administration 100 mg / ml.

bronchodilator

Solution for intravenous administration, 24 mg / ml.